HUP0202497A3 - Hydrodynamically balancing oral drug delivary system - Google Patents

Hydrodynamically balancing oral drug delivary system

Info

Publication number
HUP0202497A3
HUP0202497A3 HU0202497A HUP0202497A HUP0202497A3 HU P0202497 A3 HUP0202497 A3 HU P0202497A3 HU 0202497 A HU0202497 A HU 0202497A HU P0202497 A HUP0202497 A HU P0202497A HU P0202497 A3 HUP0202497 A3 HU P0202497A3
Authority
HU
Hungary
Prior art keywords
hydrodynamically
oral drug
delivary
balancing
balancing oral
Prior art date
Application number
HU0202497A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of HUP0202497A2 publication Critical patent/HUP0202497A2/hu
Publication of HUP0202497A3 publication Critical patent/HUP0202497A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU0202497A 1999-08-04 2000-08-01 Hydrodynamically balancing oral drug delivary system HUP0202497A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1999/001386 WO2001010405A1 (en) 1999-08-04 1999-08-04 Hydrodynamically balanced oral drug delivery system

Publications (2)

Publication Number Publication Date
HUP0202497A2 HUP0202497A2 (hu) 2002-11-28
HUP0202497A3 true HUP0202497A3 (en) 2004-05-28

Family

ID=11004886

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0202497A HUP0202497A3 (en) 1999-08-04 2000-08-01 Hydrodynamically balancing oral drug delivary system

Country Status (21)

Country Link
EP (1) EP1206249A4 (xx)
JP (1) JP2003506400A (xx)
CN (1) CN1376059A (xx)
AP (1) AP2002002410A0 (xx)
AU (2) AU5060499A (xx)
BR (1) BR0012981A (xx)
CA (1) CA2378468A1 (xx)
CZ (1) CZ2002415A3 (xx)
EA (1) EA200200126A1 (xx)
HK (1) HK1047226A1 (xx)
HR (1) HRP20020108A2 (xx)
HU (1) HUP0202497A3 (xx)
IL (1) IL147966A0 (xx)
MX (1) MXPA02001272A (xx)
NZ (1) NZ516959A (xx)
OA (1) OA12003A (xx)
PL (1) PL353321A1 (xx)
SK (1) SK1832002A3 (xx)
TR (1) TR200200467T2 (xx)
WO (2) WO2001010405A1 (xx)
ZA (1) ZA200200926B (xx)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100457458B1 (ko) * 2001-04-02 2004-11-17 삼아약품 주식회사 속용정 및 그의 제조방법
AU2002355686B2 (en) 2001-07-04 2007-11-29 Sun Pharmaceutical Industries Limited Gastric retention controlled drug delivery system
WO2003037296A2 (en) * 2001-10-29 2003-05-08 Labopharm Inc. Methods and dosage forms for improving the bioavailability of therapeutic agents
US20050226926A1 (en) 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
WO2005020879A2 (en) * 2003-08-27 2005-03-10 Vecta Ltd. Compositions for treating pathologies that necessitate suppression of gastric acid secretion
TW200533391A (en) * 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system
BRPI0513846A (pt) 2004-08-13 2008-05-20 Boehringer Ingelheim Int formulação de comprimido de liberação prolongada contendo pramipexol ou um sal farmaceuticamente aceitável do mesmo, método para a fabricação do mesmo e o uso do mesmo
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
EP1690540A1 (en) * 2005-02-15 2006-08-16 Neuro3D Composition comprising ocaperidone
US9301919B2 (en) 2005-12-22 2016-04-05 Oakwood Laboratories, Llc Sublimable sustained release delivery system and method of making same
EP1886665A1 (en) * 2006-08-01 2008-02-13 Boehringer Ingelheim Pharma GmbH & Co. KG Gastro retentive delivery system
ATE476176T1 (de) 2007-03-02 2010-08-15 Farnam Co Inc Wachsähnliches material enthaltende tabletten mit verzögerter freisetzung
CN102202656A (zh) 2008-08-15 2011-09-28 蒂宝制药公司 治疗和预防cns障碍的胃滞留药用组合物
JP2012500230A (ja) 2008-08-18 2012-01-05 北京天衡▲薬▼物研究院 胃内滞留薬物放出システム及びその製造方法と使用
AU2009301994B2 (en) 2008-10-08 2016-10-20 Bioplus Life Sciences Pvt. Ltd. Sustained release drug delivery system
EP2283824B1 (en) 2009-07-30 2017-04-19 Special Products Line S.p.A. Compositions and formulations based on swellable matrices for sustained release of poorly soluble drugs such as clarithromycin
JP2013103879A (ja) * 2011-11-10 2013-05-30 Nakanihon Capsule Co Ltd ハードカプセル
KR102241487B1 (ko) 2013-02-20 2021-04-16 주식회사 종근당 제어방출 펠릿으로 된 약제학적 조성물
ES2761407T3 (es) * 2013-03-15 2020-05-19 Aprecia Pharmaceuticals LLC Forma de dosificación rápidamente dispersable de topiramato
CN103462917A (zh) * 2013-09-12 2013-12-25 南京正宽医药科技有限公司 一种用于抗病毒的阿昔洛韦片剂及其制备方法
CN109561710A (zh) * 2016-06-14 2019-04-02 普瑞特克微生物有限责任公司 包含饲料添加剂的动物饲料颗粒、其制备和使用方法
US10588863B2 (en) 2017-06-16 2020-03-17 Kashiv Biosciences, Llc Extended release compositions comprising pyridostigmine
US10987311B2 (en) 2017-06-16 2021-04-27 Kashiv Specialty Pharmaceuticals, Llc Extended release compositions comprising pyridostigmine
US10918597B2 (en) 2017-06-16 2021-02-16 Kashiv Specialty Pharmaceuticals, Llc Gastroretentive dosage forms for sustained drug delivery
CN107375287B (zh) * 2017-08-22 2019-11-29 安徽省肿瘤医院 一种硫酸阿托品在制备治疗原发性肝癌药物中的用途
CN107349195A (zh) * 2017-08-22 2017-11-17 安徽省肿瘤医院 一种维拉帕米在制备治疗转移性肝癌药物中的用途
CN107441115A (zh) * 2017-08-22 2017-12-08 安徽省肿瘤医院 一种维拉帕米联合碳酸氢钠在制备原发性肝癌治疗药物中的用途
EP4056172A1 (en) 2018-06-18 2022-09-14 Amneal Complex Products Research LLC Extended release compositions comprising pyridostigmine
JP7034343B2 (ja) 2018-06-27 2022-03-11 アムニール コンプレックス プロダクツ リサーチ エルエルシー 自己調節性の浸透性胃保持性薬物送達システム
US11389398B2 (en) 2019-05-14 2022-07-19 Clexio Biosciences Ltd. Gastroretentive treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease
WO2022195476A1 (en) 2021-03-15 2022-09-22 Clexio Biosciences Ltd. Gastroretentive devices for assessment of intragastric conditions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH675537A5 (xx) * 1988-03-25 1990-10-15 Ciba Geigy Ag
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
US5368861A (en) * 1989-10-26 1994-11-29 Nippon Shinyaku Co., Ltd. Gastric preparation with sustained release
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
GB9322314D0 (en) * 1993-10-29 1993-12-15 Scherer Ltd R P Foam generating capsules
DE4403943A1 (de) * 1994-02-08 1995-08-10 Hexal Pharma Gmbh Orale Azrneimittelzubereitung mit Diclofenac-Natrium
GB9418530D0 (en) * 1994-09-14 1994-11-02 Glaxo Group Ltd Medicaments
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
IT1293764B1 (it) * 1997-07-23 1999-03-10 Chiesi Farma Spa Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua

Also Published As

Publication number Publication date
JP2003506400A (ja) 2003-02-18
EP1206249A1 (en) 2002-05-22
AU774957B2 (en) 2004-07-15
AU6309900A (en) 2001-03-05
NZ516959A (en) 2003-10-31
CN1376059A (zh) 2002-10-23
EA200200126A1 (ru) 2002-10-31
PL353321A1 (en) 2003-11-17
IL147966A0 (en) 2002-09-12
EP1206249A4 (en) 2004-12-22
ZA200200926B (en) 2002-11-27
OA12003A (en) 2006-04-18
BR0012981A (pt) 2002-06-18
WO2001010419A1 (en) 2001-02-15
HUP0202497A2 (hu) 2002-11-28
SK1832002A3 (en) 2002-08-06
HRP20020108A2 (en) 2003-12-31
CZ2002415A3 (cs) 2002-08-14
MXPA02001272A (es) 2002-07-22
WO2001010405A1 (en) 2001-02-15
TR200200467T2 (tr) 2002-08-21
AP2002002410A0 (en) 2002-03-31
CA2378468A1 (en) 2001-02-15
HK1047226A1 (zh) 2003-02-14
AU5060499A (en) 2001-03-05

Similar Documents

Publication Publication Date Title
HUP0202497A3 (en) Hydrodynamically balancing oral drug delivary system
NZ513700A (en) Oral drug delivery system
IL150053A0 (en) Pharmaceutical superdisintegrant
HUP0203585A3 (en) Pharmaceutical combinations
HK1042241A1 (zh) 膠囊系統
EG23858A (en) Drug combination
IL146052A0 (en) Monofluoroalkyl derivatives
IL146152A0 (en) Prucalopride oral solution
EP1150700A4 (en) ANTI-ANGIOGENIC ACTIVE SUBSTANCES
HRP20010951A2 (en) Pharmaceutical complex
GB9924506D0 (en) Expression system
HUP0004776A3 (en) Prosthesis system
GB0126074D0 (en) Tomographic system
GB9918154D0 (en) Expression system
GB9902234D0 (en) Expression system
GB9924449D0 (en) Rapid drug detection system
GB2375831B (en) Ranging system
IL126732A0 (en) Pro drug
GB0008279D0 (en) Ranging system
GB9926434D0 (en) Pharmaceutical
GB9926437D0 (en) Pharmaceutical
GB9921064D0 (en) Drug combination
GB9902593D0 (en) Drug combinations
LT99150A (en) Measuring system
GB9903785D0 (en) Indicating system